ESG Report 2023

18 Serving overseas customers over 400 Total number of countries covered by overseas exports 78 Total number of products exported overseas in the Year 26 Customers developed in the overseas market in the Year 48 40 cases Overseas Certifications Overseas Registrations 76 cases RMB 2.62 billion Overseas Business Revenue 5.2.2 Overseas Market The Group actively expands its international business, enhancing its global industrial layout and export operations. In the Year, the Group generated RMB2.62 billion in overseas business revenue, accounting for 19% of the Group's total revenue. Currently, the Group's international business covers intermediates and APIs, with a sales network spanning major pharmaceutical markets and emerging markets worldwide, including China, Europe, India, the Middle East, South America, and Africa. It holds a leading position in the upstream industry of penicillin antibiotics globally. The Group's intermediates and APIs have obtained official certifications from multiple countries, such as the European Union Certification of suitability of European Pharmacopoeia monographs (CEP), the United States FDA, Germany, India, Japan, Brazil, and Mexico. Currently, the Group has a total of 40 overseas certifications and 76 overseas registrations. Business progress in the overseas market Environmental, Social and Governance Report 2023 The United Laboratories International Holdings Limited